126 related articles for article (PubMed ID: 29461507)
1. Exploring the Metabolism of (+)-[
Ludwig FA; Fischer S; Smits R; Deuther-Conrad W; Hoepping A; Tiepolt S; Patt M; Sabri O; Brust P
Molecules; 2018 Feb; 23(2):. PubMed ID: 29461507
[TBL] [Abstract][Full Text] [Related]
2. LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.
Ludwig FA; Smits R; Fischer S; Donat CK; Hoepping A; Brust P; Steinbach J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617996
[TBL] [Abstract][Full Text] [Related]
3. (+)-[
Tiepolt S; Becker GA; Wilke S; Cecchin D; Rullmann M; Meyer PM; Barthel H; Hesse S; Patt M; Luthardt J; Wagenknecht G; Sattler B; Deuther-Conrad W; Ludwig FA; Fischer S; Gertz HJ; Smits R; Hoepping A; Steinbach J; Brust P; Sabri O
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):731-746. PubMed ID: 32935187
[TBL] [Abstract][Full Text] [Related]
4. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of metabolism, plasma protein binding and other biological parameters after administration of (-)-[(18)F]Flubatine in humans.
Patt M; Becker GA; Grossmann U; Habermann B; Schildan A; Wilke S; Deuther-Conrad W; Graef S; Fischer S; Smits R; Hoepping A; Wagenknecht G; Steinbach J; Gertz HJ; Hesse S; Schönknecht P; Brust P; Sabri O
Nucl Med Biol; 2014 Jul; 41(6):489-94. PubMed ID: 24768146
[TBL] [Abstract][Full Text] [Related]
6. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
7. Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.
Hillmer AT; Esterlis I; Gallezot JD; Bois F; Zheng MQ; Nabulsi N; Lin SF; Papke RL; Huang Y; Sabri O; Carson RE; Cosgrove KP
Neuroimage; 2016 Nov; 141():71-80. PubMed ID: 27426839
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.
Bois F; Gallezot JD; Zheng MQ; Lin SF; Esterlis I; Cosgrove KP; Carson RE; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):570-7. PubMed ID: 25858513
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of (-)-[
Bhatt S; Hillmer AT; Nabulsi N; Matuskey D; Lim K; Lin SF; Esterlis I; Carson RE; Huang Y; Cosgrove KP
Synapse; 2018 Mar; 72(3):. PubMed ID: 29105121
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors.
Fischer S; Hiller A; Smits R; Hoepping A; Funke U; Wenzel B; Cumming P; Sabri O; Steinbach J; Brust P
Appl Radiat Isot; 2013 Apr; 74():128-36. PubMed ID: 23416407
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors.
Smits R; Fischer S; Hiller A; Deuther-Conrad W; Wenzel B; Patt M; Cumming P; Steinbach J; Sabri O; Brust P; Hoepping A
Bioorg Med Chem; 2014 Jan; 22(2):804-12. PubMed ID: 24369841
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.
Gallezot JD; Esterlis I; Bois F; Zheng MQ; Lin SF; Kloczynski T; Krystal JH; Huang Y; Sabri O; Carson RE; Cosgrove KP
Synapse; 2014 Nov; 68(11):556-64. PubMed ID: 25043426
[TBL] [Abstract][Full Text] [Related]
13. (-)-[(18) F]Flubatine: evaluation in rhesus monkeys and a report of the first fully automated radiosynthesis validated for clinical use.
Hockley BG; Stewart MN; Sherman P; Quesada C; Kilbourn MR; Albin RL; Scott PJ
J Labelled Comp Radiopharm; 2013 Oct; 56(12):595-9. PubMed ID: 24285235
[TBL] [Abstract][Full Text] [Related]
14. Radiation dosimetry of the α
Kranz M; Sattler B; Tiepolt S; Wilke S; Deuther-Conrad W; Donat CK; Fischer S; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Steinbach J; Sabri O; Brust P
EJNMMI Phys; 2016 Dec; 3(1):25. PubMed ID: 27770429
[TBL] [Abstract][Full Text] [Related]
15. Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C]flumazenil, [18F]FE-PE2I, and [11C]PBR28.
Amini N; Nakao R; Schou M; Halldin C
Anal Bioanal Chem; 2013 Feb; 405(4):1303-10. PubMed ID: 23180082
[TBL] [Abstract][Full Text] [Related]
16. [(18)F]Fallypride: metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method.
Peyronneau MA; Saba W; Goutal S; Kuhnast B; Dollé F; Bottlaender M; Valette H
Nucl Med Biol; 2013 Oct; 40(7):887-95. PubMed ID: 23891202
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine.
Brust P; Patt JT; Deuther-Conrad W; Becker G; Patt M; Schildan A; Sorger D; Kendziorra K; Meyer P; Steinbach J; Sabri O
Synapse; 2008 Mar; 62(3):205-18. PubMed ID: 18088060
[TBL] [Abstract][Full Text] [Related]
18.
Ludwig FA; Fischer S; Houska R; Hoepping A; Deuther-Conrad W; Schepmann D; Patt M; Meyer PM; Hesse S; Becker GA; Zientek FR; Steinbach J; Wünsch B; Sabri O; Brust P
Front Pharmacol; 2019; 10():534. PubMed ID: 31263411
[TBL] [Abstract][Full Text] [Related]
19. Radioligand imaging of α4β2* nicotinic acetylcholine receptors in Alzheimer's disease and Parkinson's disease.
Meyer PM; Tiepolt S; Barthel H; Hesse S; Sabri O
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):376-86. PubMed ID: 25387119
[TBL] [Abstract][Full Text] [Related]
20. Norchloro-fluoro-homoepibatidine (NCFHEB) - a promising radioligand for neuroimaging nicotinic acetylcholine receptors with PET.
Deuther-Conrad W; Patt JT; Lockman PR; Allen DD; Patt M; Schildan A; Ganapathy V; Steinbach J; Sabri O; Brust P
Eur Neuropsychopharmacol; 2008 Mar; 18(3):222-9. PubMed ID: 17728108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
